AlphaYouTC
Insider selling
Terrie Curran sold $956K of Arcutis Biotherapeutics, Inc. (ARQT) stock
Terrie Curran, Dir of Arcutis Biotherapeutics, Inc. (ARQT), sold 38,200 shares of ARQT stock worth $956K, per an SEC Form 4 filed Aug 28, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 27, 2026, 1 day before it was made public.
ARQT has moved +4.4% since the trade date, from $24.87 to $25.96 (Sep 21, 2026 close).
- Traded
- Aug 27, 2026
- Disclosed
- Aug 28, 2026
- Filing delay
- 1 day
- Price since
- +4.4%
- Role
- Dir
- Source
- SEC Form 4
More ARQT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.